home

NVS.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Stock prediction for NVS.US - Novartis AG ADR

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
symbollastchange%chngnamemcapsectorwiki
NVS Novartis AG ADR 236.659B Healthcare wiki y

symbolprev.closerangecharttargetpercentperiodmonthsduerating
 A  NVS 107.08 0,0.519,0.025,0.906,0.519 112.15,110.80,113.10,117.40,120.06,117.75,116.16,116.11,116.09,114.35,114.86,116.56,114.21,110.76,108.33 117.51-125.93 13.67% 267,126,267 4.7 Jul 5-Mar 29 70.75%

stock prediction graph

prediction values

stocklow targettargethigh targetto go daystarget date
NVS 117.51 121.72 125.93 13.74% 267 Mar 29
NVS 114.36 117.61 120.87 9.89% 177 Dec 29
NVS 114.23 117.35 120.47 9.64% 167 Dec 19
NVS 113.95 116.96 119.96 9.27% 157 Dec 9
NVS 113.74 116.60 119.45 8.93% 147 Nov 29
NVS 113.60 116.35 119.11 8.71% 137 Nov 19
NVS 113.17 115.78 118.40 8.17% 127 Nov 9
NVS 112.12 114.67 117.21 7.12% 117 Oct 30
NVS 112.12 114.51 116.90 6.97% 107 Oct 20
NVS 111.38 113.66 115.93 6.18% 97 Oct 10
``` ```